DrStockPick.com Stock Report!
Thursday August 27, 2009
Fujitsu Microelectronics Limited and Taiwan Semiconductor Manufacturing Company, Ltd. (NYSE: TSM) today announced that they have agreed to collaborate on 28-nanometer (nm) process technology targeted for foundry production of Fujitsu Microelectronics’ 28nm logic ICs and to jointly develop an enhanced 28nm high-performance process technology by utilizing TSMC’s advanced technology platform. Previously, both companies announced that Fujitsu Microelectronics will collaborate with TSMC on 40nm production. This will extend Fujitsu Microelectronics’ 40nm collaboration with TSMC and covers joint development of an optimized 28nm high-performance process technology. Initial 28nm samples are expected to ship toward the end of 2010.
UCB and Immunomedics (Nasdaq:IMMU) announced today top-line results from UCB’s phase IIb clinical study comparing epratuzumab to placebo in patients with systemic lupus erythematosus (SLE, also commonly known as lupus). The data from the 12-week dose and regimen-ranging study demonstrated clinical meaningful treatment effect of epratuzumab over placebo in SLE patients. The 227 patients in this study had moderately (30%) to severely (70%) active disease in multiple organ systems.
Waters Corporation (NYSE: WAT) today exhibited for the first time in Europe the Waters((R)) SYNAPT(TM) G2 a system offering scientists greater power, versatility and speed at the 18(th) International Mass Spectrometry Conference (IMSC). Rounding out its display of mass spectrometry (MS) and UltraPerformance Liquid Chromatography (UPLC((R)))/MS systems at IMSC will be Waters Xevo(TM) family of tandem quadrupole and time-of-flight mass spectrometers noted for their ease-of-use and versatility.
Chunghwa Telecom Co., Ltd (NYSE: CHT), today reported its operating results for the first six months of 2009. All figures were presented on a consolidated basis and prepared in accordance to generally accepted accounting principles in the Republic of China.
Toll Brothers, Inc. (NYSE:TOL) (www.tollbrothers.com), the nation’s leading builder of luxury homes, today reported final results for its third quarter ended July 31, 2009. In FY 2009’s third quarter, the Company reported a net loss of $472.3 million, or $2.93 per share diluted. The Company’s results were impacted by non-cash federal and state deferred tax asset valuation allowances of $439.4 million, and non-cash pre-tax write-downs totaling $115.0 million. Excluding write-downs, the Company’s pre-tax earnings were $3.7 million.
Xinhua Sports & Entertainment Limited (Nasdaq: XSEL), a leading sports and entertainment media company in China, today announced that the Company will present at Rodman & Renshaw’s Annual Global Investment Conference to be held from September 9-11, 2009 at the Palace Hotel in New York City.
No comments:
Post a Comment